Updated information on COVID-19 and Flu: Restricted visitation is now in effect
Category
Cancer
Sub Category
Lung
Study Name
S1900C
Principal Investigator
Gordan Srkalovic
Study Information
(LungMap Substudy) Phase II Study of Talazoparib Plus Avelumab in Patients with Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer Bearing Pathogenic STK11 Genomic Alterations - https://clinicaltrials.gov/ct2/show/NCT04173507
Contact for Questions
Tracy RN, 517-364-2835

Site view: at a glance